Maric-Bilkan Christine, Gilbert Emily L, Ryan Michael J
Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, Bethesda, MD.
Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, USA.
Int J Womens Health. 2014 Jan 24;6:131-9. doi: 10.2147/IJWH.S38084. eCollection 2014.
Arterial blood pressure levels and the prevalence of hypertension are generally lower in premenopausal women compared with age-matched men. The lower blood pressure levels in premenopausal women are associated with a lower risk of the development and progression of cardiovascular disease. In contrast, menopause, a state characterized by a physiologic reduction in ovarian hormone levels, is associated with progressive increases in blood pressure and an overall increase in the risk of cardiovascular disease. These observations suggest an association between blood pressure regulation and changes in ovarian hormone levels, estrogens in particular. In addition to menopause, the risk of hypertension and cardiovascular disease is also dramatically increased in premenopausal women with chronic diseases such as diabetes and systemic lupus erythematosus. Studies suggest that these chronic diseases may be associated with an imbalance in ovarian hormones, which may explain the increased risk of hypertension and cardiovascular disease in these women. However, the use of hormone therapy to manage the risk and prevent the development of hypertension and cardiovascular diseases in women remains controversial. The precise mechanisms by which estrogens contribute to the regulation of blood pressure are still not completely understood. However, accumulating evidence suggests that modulating the activity of locally active hormone systems is one of the major mechanisms by which estrogens exert their effects on target organs, including the vasculature, kidneys, and immune system. In particular, the interaction between estrogens and the renin-angiotensin system has been implicated in the regulation of blood pressure and cardiovascular function in both humans and experimental models. This review summarizes our current understanding of the mechanisms by which estrogens regulate blood pressure and the potential use of hormone therapy in prevention of hypertension and consequent cardiovascular risk.
与年龄匹配的男性相比,绝经前女性的动脉血压水平和高血压患病率通常较低。绝经前女性较低的血压水平与心血管疾病发生和进展风险较低相关。相反,绝经是一种以卵巢激素水平生理性降低为特征的状态,与血压逐渐升高以及心血管疾病总体风险增加相关。这些观察结果表明血压调节与卵巢激素水平变化之间存在关联,尤其是雌激素。除绝经外,患有糖尿病和系统性红斑狼疮等慢性疾病的绝经前女性患高血压和心血管疾病的风险也会显著增加。研究表明,这些慢性疾病可能与卵巢激素失衡有关,这可能解释了这些女性患高血压和心血管疾病风险增加的原因。然而,使用激素疗法来管理女性患高血压和心血管疾病的风险并预防其发生仍存在争议。雌激素调节血压的确切机制仍未完全了解。然而,越来越多的证据表明,调节局部活性激素系统的活性是雌激素对包括血管系统、肾脏和免疫系统在内的靶器官发挥作用的主要机制之一。特别是,雌激素与肾素-血管紧张素系统之间的相互作用已被认为与人类和实验模型中的血压调节及心血管功能有关。本综述总结了我们目前对雌激素调节血压机制的理解以及激素疗法在预防高血压和随之而来的心血管风险方面的潜在用途。